Active	Status	Sponsor type	Region	Phase	Filter
3 Active 18 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Berman, Brian
NCT06771323: Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia	Not yet recruiting	2	20	US	Valbenazine, Placebo	Virginia Commonwealth University, Neurocrine Biosciences	Cervical Dystonia	01/26	01/26
NCT05157763: A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma	Recruiting	1/2	32	US	EscharEx 5% (EX-02 formulation), EX-02 5%	MediWound Ltd	Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma	05/22	06/22
CNXR-001D, NCT05279495: Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers	Completed	N/A	20	US	In a double-blinded fashion, 250 mg CANNAXR cream, TOPICAL CBD CANNAXR Cream, Topical VEHICLE cream	MINO Labs, LLC	Photoaging	04/23	05/23